• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在炎症性肌病患者中,运动监测器的可靠性、有效性和反应性。

Reliability, validity and responsiveness of physical activity monitors in patients with inflammatory myopathy.

机构信息

Department of Epidemiology.

Department of Medicine.

出版信息

Rheumatology (Oxford). 2021 Dec 1;60(12):5713-5723. doi: 10.1093/rheumatology/keab236.

DOI:10.1093/rheumatology/keab236
PMID:33714992
Abstract

OBJECTIVE

Idiopathic inflammatory myopathies (IIMs) cause proximal muscle weakness, which affects the ability to carry out the activities of daily living. Wearable physical activity monitors (PAMs) objectively assess continuous activity and potentially have clinical usefulness in the assessment of IIMs. We examined the psychometric characteristics for PAM outcomes in IIMs.

METHODS

Adult IIM patients were prospectively evaluated (at baseline, 3 months and 6 months) in an observational study. A waist-worn PAM (ActiGraph GT3X-BT) assessed average step counts/minute, peak 1-minute cadence, and vector magnitude/minute. Validated myositis core set measures (CSMs) including manual muscle testing (MMT), physician global disease activity (MD global), patient global disease activity (Pt global), extramuscular disease activity (Ex-muscular global), HAQ-DI (HAQ disability index), muscle enzymes, and patient-reported physical function were evaluated. Test-retest reliability, construct validity, and responsiveness were determined for PAM measures and CSMs, using Pearson correlations and other appropriate analyses.

RESULTS

A total of 50 adult IIM patients enrolled [mean (s.d.) age, 53.6 (14.6); 60% female, 94% Caucasian]. PAM measures showed strong test-retest reliability, moderate-to-strong correlations at baseline with MD global (r = -0.37 to -0.48), Pt global (r=-0.43 to -0.61), HAQ-DI (r = -0.47 to -0.59) and MMT (r = 0.37-0.52), and strong discriminant validity for categorical MMT and HAQ-DI. Longitudinal associations with MD global (r=-0.38 to -0.44), MMT (r = 0.50-0.57), HAQ-DI (r = -0.45 to -0.55) and functional tests (r = 0.30-0.65) were moderate to strong. PAM measures were responsive to MMT improvement ≥10% and moderate-to-major improvement on ACR/EULAR myositis response criteria. Peak 1-minute cadence had the largest effect size and standardized response means.

CONCLUSION

PAM measures showed promising construct validity, reliability, and longitudinal responsiveness; especially peak 1-minute cadence. PAMs are able to provide valid outcome measures for future use in IIM clinical trials.

摘要

目的

特发性炎性肌病(IIM)可导致近端肌肉无力,从而影响日常生活活动能力。可穿戴式身体活动监测器(PAM)可客观评估连续活动,并且在评估 IIM 方面具有潜在的临床意义。我们检查了 PAM 结果在 IIM 中的心理测量特性。

方法

在一项观察性研究中,前瞻性评估了成年 IIM 患者(基线、3 个月和 6 个月时)。佩戴在腰部的 PAM(ActiGraph GT3X-BT)评估平均每分钟步数、最高 1 分钟步频和矢量幅度/分钟。评估了经过验证的肌炎核心组测量指标(CSMs),包括手动肌肉测试(MMT)、医生整体疾病活动度(MD global)、患者整体疾病活动度(Pt global)、肌肉外疾病活动度(Ex-muscular global)、HAQ-DI(残疾指数)、肌肉酶和患者报告的身体功能。使用 Pearson 相关和其他适当的分析方法,确定了 PAM 测量指标和 CSMs 的测试-重测信度、结构效度和反应度。

结果

共纳入 50 名成年 IIM 患者[平均(标准差)年龄,53.6(14.6);60%女性,94%白种人]。PAM 测量值具有很强的测试-重测信度,在基线时与 MD global(r=-0.37 至-0.48)、Pt global(r=-0.43 至-0.61)、HAQ-DI(r=-0.47 至-0.59)和 MMT(r=0.37-0.52)具有中度至强相关性,对 MMT 和 HAQ-DI 的分类具有很强的判别效度。与 MD global(r=-0.38 至-0.44)、MMT(r=0.50-0.57)、HAQ-DI(r=-0.45 至-0.55)和功能测试(r=0.30-0.65)的纵向关联为中度至强。PAM 测量值对 MMT 改善≥10%和 ACR/EULAR 肌炎反应标准的中度至主要改善具有反应性。最高 1 分钟步频的效应量和标准化反应均值最大。

结论

PAM 测量值具有良好的结构效度、可靠性和纵向反应性;特别是最高 1 分钟步频。PAM 能够提供有效的结局测量指标,未来可用于 IIM 临床试验。

相似文献

1
Reliability, validity and responsiveness of physical activity monitors in patients with inflammatory myopathy.在炎症性肌病患者中,运动监测器的可靠性、有效性和反应性。
Rheumatology (Oxford). 2021 Dec 1;60(12):5713-5723. doi: 10.1093/rheumatology/keab236.
2
Utility of patient-reported outcomes measurement information system (PROMIS) physical function form in inflammatory myopathy.患者报告结局测量信息系统(PROMIS)在炎性肌病中的应用。
Semin Arthritis Rheum. 2021 Jun;51(3):539-546. doi: 10.1016/j.semarthrit.2021.03.018. Epub 2021 Apr 15.
3
Consumer-based activity trackers in evaluation of physical activity in myositis patients.基于消费者的活动追踪器在评估肌炎患者的身体活动中的应用。
Rheumatology (Oxford). 2022 Jul 6;61(7):2951-2958. doi: 10.1093/rheumatology/keab700.
4
Hand-held dynamometry for assessment of muscle strength in patients with inflammatory myopathies.手持式测力计评估炎症性肌病患者的肌肉力量。
Rheumatology (Oxford). 2021 May 14;60(5):2146-2156. doi: 10.1093/rheumatology/keaa419.
5
Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies.儿童肌炎评估量表在幼年特发性炎性肌病肌肉功能评估中的效度及临床意义
Arthritis Rheum. 2004 May;50(5):1595-603. doi: 10.1002/art.20179.
6
Construct validity of PROMIS pain interference, fatigue, and physical function as patient-reported outcomes in adults with idiopathic inflammatory myopathies: An international study from the OMERACT myositis working group.特发性炎性肌病患者报告结局测量(PROMIS)疼痛干扰、疲劳和躯体功能的结构效度:OMERACT 肌炎工作组的一项国际研究。
Semin Arthritis Rheum. 2024 Oct;68:152534. doi: 10.1016/j.semarthrit.2024.152534. Epub 2024 Aug 10.
7
Discordance between patient- and physician-reported disease activity in adult idiopathic inflammatory myopathy.成人特发性炎性肌病中患者报告与医生报告的疾病活动的差异。
Rheumatology (Oxford). 2023 Dec 1;62(12):3957-3961. doi: 10.1093/rheumatology/kead316.
8
Validation of two simple patient-centered outcome measures for virtual monitoring of patients with idiopathic inflammatory myositis.验证两种简单的以患者为中心的结局测量指标,用于特发性炎性肌病患者的虚拟监测。
Clin Rheumatol. 2022 Mar;41(3):765-772. doi: 10.1007/s10067-021-05990-3. Epub 2021 Nov 17.
9
A review of the evidence for the utility of physical activity monitor use in patients with idiopathic inflammatory myopathies.特发性炎性肌病患者使用身体活动监测器的效用的证据回顾。
Rheumatology (Oxford). 2024 Jul 1;63(7):1815-1824. doi: 10.1093/rheumatology/keae004.
10
Assessment of disability in idiopathic inflammatory myopathy: a call for linearity.特发性炎性肌病残疾评估:呼吁线性化。
Rheumatology (Oxford). 2022 Aug 3;61(8):3420-3426. doi: 10.1093/rheumatology/keab906.

引用本文的文献

1
High-intensity resistance training in patients with myositis - 1-year follow-up on a randomised controlled trial.肌炎患者的高强度抗阻训练——一项随机对照试验的1年随访
Rheumatol Int. 2025 Apr 16;45(5):104. doi: 10.1007/s00296-025-05858-8.
2
Rheumatology in the digital health era: status quo and quo vadis?数字健康时代的风湿病学:现状与未来走向?
Nat Rev Rheumatol. 2024 Dec;20(12):747-759. doi: 10.1038/s41584-024-01177-7. Epub 2024 Oct 31.
3
Disease characteristics and medications use in idiopathic inflammatory myopathy: a multi-centre prospective observational study of decentralized remote vs. traditional clinic enrolment.
特发性炎性肌病的疾病特征与药物使用:一项关于分散式远程招募与传统门诊招募的多中心前瞻性观察研究。
Rheumatology (Oxford). 2025 Apr 1;64(4):2099-2105. doi: 10.1093/rheumatology/keae467.
4
Clinical features associated with the presence of anti-Ro52 and anti-Ro60 antibodies in Jo-1 antibody-positive anti-synthetase syndrome.抗合成酶抗体阳性的抗 Jo-1 抗体阳性的抗合成酶综合征中与抗 Ro52 和抗 Ro60 抗体存在相关的临床特征。
Front Immunol. 2024 Jun 4;15:1399451. doi: 10.3389/fimmu.2024.1399451. eCollection 2024.
5
Patient-reported outcome for physical function in idiopathic inflammatory myopathy.特发性炎性肌病中患者报告的身体功能结局
Rheumatology (Oxford). 2025 Feb 1;64(2):763-770. doi: 10.1093/rheumatology/keae091.
6
Digital Approaches for Myositis.肌炎的数字化方法。
Curr Rheumatol Rep. 2023 Dec;25(12):259-263. doi: 10.1007/s11926-023-01119-4. Epub 2023 Nov 14.
7
Measurement properties of device-based physical activity instruments in ambulatory adults with physical disabilities and/or chronic diseases: a scoping review.针对患有身体残疾和/或慢性病的非卧床成年人,基于设备的身体活动测量仪器的测量属性:一项范围综述
BMC Sports Sci Med Rehabil. 2023 Sep 21;15(1):115. doi: 10.1186/s13102-023-00717-0.
8
Treatment with add-on IVIg in Myositis Early In the diSease course May be sUperior to Steroids alone for reaching CLinical improvEment (TIME IS MUSCLE): study protocol of a phase-2 double-blind placebo-controlled randomised trial.在疾病早期,联合 IVIg 治疗可能优于单独使用类固醇治疗,以达到临床改善(TIME IS MUSCLE):一项 2 期双盲安慰剂对照随机试验的研究方案。
BMJ Open. 2023 Jul 10;13(7):e067435. doi: 10.1136/bmjopen-2022-067435.
9
Pain in autoimmune inflammatory myopathies: a scoping review.自身免疫性炎性肌病中的疼痛:范围综述。
RMD Open. 2023 Jan;9(1). doi: 10.1136/rmdopen-2022-002591.
10
Reliability and validity of PROMIS physical function, pain interference, and fatigue as patient reported outcome measures in adult idiopathic inflammatory myopathies: International study from the OMERACT myositis working group.PROMIS 物理功能、疼痛干扰和疲劳作为成人特发性炎性肌病患者报告结局测量的可靠性和有效性:OMERACT 肌炎工作组的国际研究。
Semin Arthritis Rheum. 2023 Feb;58:152111. doi: 10.1016/j.semarthrit.2022.152111. Epub 2022 Nov 3.